Targeting AMP kinase in melanoma: A phase I trial of phenformin with dabrafenib/trametinib.

Category Primary study
JournalJOURNAL OF CLINICAL ONCOLOGY
Year 2023
This article has no abstract
Epistemonikos ID: 897f429f6ffd572dac0bd5f1c1c52f16f2e05521
First added on: Feb 16, 2025